Improving access to clinical trials
Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to be part of one.
Expanding trial access – ICR report
Our 2021 report, Clinical trials in cancer, reveals the impact of the Covid-19 pandemic on cancer trials and highlights longstanding barriers to expanding clinical trial access to more people with cancer. But Covid-19 also offers clues to a recovery that can get new treatments to cancer patients more quickly.
News: Cancer trial recruitment drops by 60 per cent during pandemic
The number of cancer patients entering clinical trials has plummeted during the pandemic – denying many thousands the latest treatment options and delaying drug development. Here, cancer experts set out their findings about the barriers to carrying out clinical trials in the UK and proposals for boosting participation.Latest ICR News
Targeting cancer cell DNA repair mechanism may make radiotherapy more effective
Scientists have uncovered a mechanism that helps cancer cells survive radiation, pointing to a potential new way to make treatment more effective.
ICR welcomes FDA approval of capivasertib for advanced prostate cancer
The Institute of Cancer Research, London, strongly welcomes the news that the targeted drug capivasertib, has been approved by the US Food and Drug Administration (FDA) for treating a type of advanced prostate cancer.
---945x532.jpg?sfvrsn=73000500_2 "radiotherapy IMRT (photo: Jan Chlebik/the ICR) - 945x532")
Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS
Thousands of men with prostate cancer in England will be offered a more precise form of radiotherapy that cuts treatment time by up to 75 per cent, based on the results of a trial led by The Institute of Cancer Research (ICR), London and Royal Marsden NHS Foundation Trust. The therapy is known as SABR or SBRT.
New study explores the use of powerful electron beams to treat cancer
Scientists have explored how a new high-powered laboratory accelerator could one day be used to treat cancer, offering new insights into an emerging form of radiotherapy known as FLASH.